Central effects of tetanus and botulinum neurotoxins

Toxicon

Volumn 54, Issue 5, 2009, Pages 593-599

  Caleo, Matteo ^a   Schiavo, Giampietro ^b  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Epilepsy; Motoneurons; Neuromuscular junction; Neuronal activity; Neurotransmitter release; Retrograde axonal transport

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; GANGLIOSIDE GD 1B; GUANOSINE TRIPHOSPHATASE; LECTIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SYNAPTOBREVIN; TETANUS TOXIN;

ANTICONVULSANT THERAPY; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; BOTULISM; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; DRUG CONJUGATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG TRANSPORT; DYSTONIA; ENZYME ACTIVE SITE; FOCAL EPILEPSY; HUMAN; INTERNALIZATION; LIMB ISCHEMIA; MOTONEURON; NERVE CELL PLASTICITY; NEUROMUSCULAR SYNAPSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PAIN; PRIORITY JOURNAL; SEIZURE; SYNAPTIC TRANSMISSION; TEMPORAL LOBE EPILEPSY; TOXIN ANALYSIS; TRANSCYTOSIS; TRANSPORT KINETICS;

ANIMALS; BOTULINUM TOXINS; CENTRAL NERVOUS SYSTEM; EXOCYTOSIS; HUMANS; METALLOPROTEASES; MOTOR NEURONS; NEURAL PATHWAYS; NEUROTOXINS; PROTEIN BINDING; SYNAPTIC TRANSMISSION; TETANUS TOXIN;

EID: 68849129297     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2008.12.026     Document Type: Article

References (90)

1. Abbruzzese G., and Berardelli A. Neurophysiological effects of botulinum toxin type A. Neurotox. Res. 9 (2006) 109-114
2. Ando S., Kobayashi S., Waki H., Kon K., Fukui F., Tadenuma T., Iwamoto M., Takeda Y., Izumiyama N., Watanabe K., and Nakamura H. Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine. J. Neurosci. Res. 70 (2002) 519-527
3. Antonucci F., Di Garbo A., Novelli E., Manno I., Sartucci F., Bozzi Y., and Caleo M. Botulinum neurotoxin E (BoNT/E) reduces CA1 neuron loss and granule cell dispersion, with no effects on chronic seizures, in a mouse model of temporal lobe epilepsy. Exp. Neurol. 210 (2008) 388-401
4. Antonucci F., Rossi C., Gianfranceschi L., Rossetto O., and Caleo M. Long-distance retrograde effects of botulinum neurotoxin A. J. Neurosci. 28 (2008) 3689-3696
5. Antonucci F., Bozzi Y., and Caleo M. Intrahippocampal infusion of botulinum neurotoxin E (BoNT/E) reduces spontaneous recurrent seizures in a mouse model of mesial temporal lobe epilepsy. Epilepsia. Epub Jan 19 (2009) 2009
6. Ashton A.C., and Dolly J.O. Characterization of the inhibitory action of botulinum neurotoxin type A on the release of several transmitters from rat cerebrocortical synaptosomes. J. Neurochem. 50 (1988) 1808-1816
7. Baldwin M.R., and Barbieri J.T. Association of botulinum neurotoxin serotypes A and B with synaptic vesicle protein complexes. Biochemistry 46 (2007) 3200-3210
8. Bilsland L.G., and Schiavo G. Axonal transport tracers. In: Squire L.R. (Ed). The New Encyclopedia of Neuroscience (2008), Academic Press, Oxford (UK) 1209-1216
9. Bizzini B., Grob P., Glicksman M.A., and Akert K. Use of the B-IIb tetanus toxin derived fragment as a specific neuropharmacological transport agent. Brain Res. 193 (1980) 221-227
10. Bohnert S., and Schiavo G. Tetanus toxin is transported in a novel neuronal compartment characterized by a specialized pH regulation. J. Biol. Chem. 280 (2005) 42336-42344
11. Boroff D.A., and Chen G.S. On the question of permeability of the blood-brain barrier to botulinum toxin. Int. Arch. Allergy Appl. Immunol. 48 (1975) 495-504
12. Bozzi Y., Costantin L., Antonucci F., and Caleo M. Action of botulinum neurotoxins in the central nervous system: antiepileptic effects. Neurotox. Res. 9 (2006) 197-203
13. Brener K., Amitai Y., Jefferys J.G., and Gutnick M.J. Chronic epileptic foci in neocortex: in vivo and in vitro effects of tetanus toxin. Eur. J. Neurosci. 3 (1991) 47-54
14. Byrnes M.L., Thickbroom G.W., Wilson S.A., Sacco P., Shipman J.M., Stell R., and Mastaglia F.L. The corticomotor representation of upper limb muscles in writer's cramp and changes following botulinum toxin injection. Brain 121 Pt 5 (1998) 977-988
15. Caleo M., Restani L., Gianfranceschi L., Costantin L., Rossi C., Rossetto O., Montecucco C., and Maffei L. Transient synaptic silencing of developing striate cortex has persistent effects on visual function and plasticity. J. Neurosci. 27 (2007) 4530-4540
16. Capogna M., McKinney R.A., O'Connor V., Gahwiler B.H., and Thompson S.M. Ca2+ or Sr2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin. J. Neurosci. 17 (1997) 7190-7202
17. Chaddock J.A., Purkiss J.R., Alexander F.C., Doward S., Fooks S.J., Friis L.M., Hall Y.H., Kirby E.R., Leeds N., Moulsdale H.J., Dickenson A., Green G.M., Rahman W., Suzuki R., Duggan M.J., Quinn C.P., Shone C.C., and Foster K.A. Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain. Mov. Disord. 19 Suppl. 8 (2004) S42-S47
18. Chen C., Baldwin M.R., and Barbieri J.T. Molecular basis for tetanus toxin coreceptor interactions. Biochemistry 47 (2008) 7179-7186
19. Costantin L., Bozzi Y., Richichi C., Viegi A., Antonucci F., Funicello M., Gobbi M., Mennini T., Rossetto O., Montecucco C., Maffei L., Vezzani A., and Caleo M. Antiepileptic effects of botulinum neurotoxin E. J. Neurosci. 25 (2005) 1943-1951
20. Curra A., Trompetto C., Abbruzzese G., and Berardelli A. Central effects of botulinum toxin type A: evidence and supposition. Mov. Disord. 19 Suppl. 8 (2004) S60-S64
21. Darcy K.J., Staras K., Collinson L.M., and Goda Y. Constitutive sharing of recycling synaptic vesicles between presynaptic boutons. Nat. Neurosci. 9 (2006) 315-321
22. Davletov B., Bajohrs M., and Binz T. Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins. Trends Neurosci. 28 (2005) 446-452
23. Deinhardt K., Berninghausen O., Willison H.J., Hopkins C.R., and Schiavo G. Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1. J. Cell Biol. 174 (2006) 459-471
24. Deinhardt K., Salinas S., Verastegui C., Watson R., Worth D., Hanrahan S., Bucci C., and Schiavo G. Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 52 (2006) 293-305
25. Dong M., Richards D.A., Goodnough M.C., Tepp W.H., Johnson E.A., and Chapman E.R. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol. 162 (2003) 1293-1303
26. Dong M., Tepp W.H., Liu H., Johnson E.A., and Chapman E.R. Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons. J. Cell Biol. 179 (2007) 1511-1522
27. Dong M., Yeh F., Tepp W.H., Dean C., Johnson E.A., Janz R., and Chapman E.R. SV2 is the protein receptor for botulinum neurotoxin A. Science 312 (2006) 592-596
28. Duggan M.J., Quinn C.P., Chaddock J.A., Purkiss J.R., Alexander F.C., Doward S., Fooks S.J., Friis L.M., Hall Y.H., Kirby E.R., Leeds N., Moulsdale H.J., Dickenson A., Green G.M., Rahman W., Suzuki R., Shone C.C., and Foster K.A. Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin. J. Biol. Chem. 277 (2002) 34846-34852
29. Fernandez-Salas E., Garay P., Jacky B., Dupuy J., Wang J., Nelson J., Raymond C.S., and Aoki K.R. Identification of the fibroblast growth factor receptor FGFR3 as a component of the receptor complex for Botulinum Neurotoxin Type A. Toxicon 5 Suppl. 1 (2008) 3
30. Filippi G.M., Errico P., Santarelli R., Bagolini B., and Manni E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol. 113 (1993) 400-404
31. Foran P.G., Mohammed N., Lisk G.O., Nagwaney S., Lawrence G.W., Johnson E., Smith L., Aoki K.R., and Dolly J.O. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J. Biol. Chem. 278 (2003) 1363-1371
32. Francis J.W., Hosler B.A., Brown Jr. R.H., and Fishman P.S. CuZn superoxide dismutase (SOD-1):tetanus toxin fragment C hybrid protein for targeted delivery of SOD-1 to neuronal cells. J. Biol. Chem. 270 (1995) 15434-15442
33. Garbelli R., Inverardi F., Medici V., Amadeo A., Verderio C., Matteoli M., and Frassoni C. Heterogeneous expression of SNAP-25 in rat and human brain. J. Comp. Neurol. 506 (2008) 373-386
34. Garner C.G., Straube A., Witt T.N., Gasser T., and Oertel W.H. Time course of distant effects of local injections of botulinum toxin. Mov. Disord. 8 (1993) 33-37
35. Gil C., Chaib-Oukadour I., and Aguilera J. C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signalling pathways in a Trk receptor-dependent manner in cultured cortical neurons. Biochem. J. 373 (2003) 613-620
36. Gilio F., Curra A., Lorenzano C., Modugno N., Manfredi M., and Berardelli A. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann. Neurol. 48 (2000) 20-26
37. Gracies J.M. Physiological effects of botulinum toxin in spasticity. Mov. Disord. 19 Suppl. 8 (2004) S120-S128
38. Habermann E. 125I-labeled neurotoxin from Clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord. Naunyn Schmiedebergs Arch. Pharmacol. 281 (1974) 47-56
39. Herreros J., Ng T., and Schiavo G. Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons. Mol. Biol. Cell 12 (2001) 2947-2960
40. Hughes R., and Whaler B.C. Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum type A toxin. J. Physiol. 160 (1962) 221-233
41. Jahn R., and Sudhof T.C. Membrane fusion and exocytosis. Annu. Rev. Biochem. 68 (1999) 863-911
42. Jefferys J.G.R., and Walker M.C. Tetanus toxin model of focal epilepsy. In: Pitkanen A., Schwartzkroin P.A., and Moshè S.L. (Eds). Models of Seizures and Epilepsy (2006), Elsevier Academic Press, London 407-414
43. Jiang M., Lee C.L., Smith K.L., and Swann J.W. Spine loss and other persistent alterations of hippocampal pyramidal cell dendrites in a model of early-onset epilepsy. J. Neurosci. 18 (1998) 8356-8368
44. Keller J.E., Cai F., and Neale E.A. Uptake of botulinum neurotoxin into cultured neurons. Biochemistry 43 (2004) 526-532
45. Koriazova L.K., and Montal M. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat. Struct. Biol. 10 (2003) 13-18
46. Lalli G., Bohnert S., Deinhardt K., Verastegui C., and Schiavo G. The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol. 11 (2003) 431-437
47. Lalli G., Gschmeissner S., and Schiavo G. Myosin Va and microtubule-based motors are required for fast axonal retrograde transport of tetanus toxin in motor neurons. J. Cell Sci. 116 (2003) 4639-4650
48. Luvisetto S., Marinelli S., Lucchetti F., Marchi F., Cobianchi S., Rossetto O., Montecucco C., and Pavone F. Botulinum neurotoxins and formalin-induced pain: central vs. peripheral effects in mice. Brain Res. 1082 (2006) 124-131
49. Mahrhold S., Rummel A., Bigalke H., Davletov B., and Binz T. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett. 580 (2006) 2011-2014
50. Manno I., Antonucci F., Caleo M., and Bozzi Y. BoNT/E prevents seizure-induced activation of caspase 3 in the rat hippocampus. Neuroreport 18 (2007) 373-376
51. Matteoli M., Verderio C., Rossetto O., Iezzi N., Coco S., Schiavo G., and Montecucco C. Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 13310-13315
52. Meunier F.A., Schiavo G., and Molgo J. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J. Physiol. Paris 96 (2002) 105-113
53. Miana-Mena F.J., Munoz M.J., Ciriza J., Soria J., Brulet P., Zaragoza P., and Osta R. Fragment C tetanus toxin: a putative activity-dependent neuroanatomical tracer. Acta Neurobiol. Exp. (Wars) 63 (2003) 211-218
54. Montecucco C. How do tetanus and botulinum neurotoxins bind to neuronal membranes?. Trends Biochem. Sci. 11 (1986) 315-317
55. Montecucco C., and Molgo J. Botulinal neurotoxins: revival of an old killer. Curr. Opin. Pharmacol. 5 (2005) 274-279
56. Montecucco C., Rossetto O., and Schiavo G. Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol. 12 (2004) 442-446
57. Moreno-Lopez B., de la Cruz R.R., Pastor A.M., and Delgado-Garcia J.M. Botulinum neurotoxin alters the discharge characteristics of abducens motoneurons in the alert cat. J. Neurophysiol. 72 (1994) 2041-2044
58. Moreno-Lopez B., de la Cruz R.R., Pastor A.M., and Delgado-Garcia J.M. Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: alterations of the discharge pattern. Neuroscience 81 (1997) 437-455
59. Moreno-Lopez B., Pastor A.M., de la Cruz R.R., and Delgado-Garcia J.M. Dose-dependent, central effects of botulinum neurotoxin type A: a pilot study in the alert behaving cat. Neurology 48 (1997) 456-464
60. Naumann M., So Y., Argoff C.E., Childers M.K., Dykstra D.D., Gronseth G.S., Jabbari B., Kaufmann H.C., Schurch B., Silberstein S.D., and Simpson D.M. Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70 (2008) 1707-1714
61. Nilsen K.E., Walker M.C., and Cock H.R. Characterization of the tetanus toxin model of refractory focal neocortical epilepsy in the rat. Epilepsia 46 (2005) 179-187
62. Pastor A.M., Moreno-Lopez B., De La Cruz R.R., and Delgado-Garcia J.M. Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: ultrastructural and synaptic alterations. Neuroscience 81 (1997) 457-478
63. Perreault M.C., Bernier A.P., Renaud J.S., Roux S., and Glover J.C. C fragment of tetanus toxin hybrid proteins evaluated for muscle-specific transsynaptic mapping of spinal motor circuitry in the newborn mouse. Neuroscience 141 (2006) 803-816
64. Pitkanen A., and Sutula T.P. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 1 (2002) 173-181
65. Polley E.H., Vick J.A., Ciuchta H.P., Fischetti D.A., Macchitelli F.J., and Montanarelli N. Botulinum Toxin, Type a: effects on central nervous system. Science 147 (1965) 1036-1037
66. Priori A., Berardelli A., Mercuri B., and Manfredi M. Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain 118 Pt 3 (1995) 801-807
67. Rind H.B., Butowt R., and von Bartheld C.S. Synaptic targeting of retrogradely transported trophic factors in motoneurons: comparison of glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor, and cardiotrophin-1 with tetanus toxin. J. Neurosci. 25 (2005) 539-549
68. Roux S., Colasante C., Saint Cloment C., Barbier J., Curie T., Girard E., Molgo J., and Brulet P. Internalization of a GFP-tetanus toxin C-terminal fragment fusion protein at mature mouse neuromuscular junctions. Mol. Cell Neurosci. 30 (2005) 572-582
69. Rummel A., Bade S., Alves J., Bigalke H., and Binz T. Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity. J. Mol. Biol. 326 (2003) 835-847
70. Rummel A., Eichner T., Weil T., Karnath T., Gutcaits A., Mahrhold S., Sandhoff K., Proia R.L., Acharya K.R., Bigalke H., and Binz T. Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 359-364
71. Rummel A., Karnath T., Henke T., Bigalke H., and Binz T. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J. Biol. Chem. 279 (2004) 30865-30870
72. Santini M., Fabri S., Sagnelli P., Manfredi M., and Francia A. Botulism: a case associated with pyramidal signs. Eur. J. Neurol. 6 (1999) 91-93
73. Schiavo G. Structural biology: dangerous liaisons on neurons. Nature 444 (2006) 1019-1020
74. Simpson D.M., Blitzer A., Brashear A., Comella C., Dubinsky R., Hallett M., Jankovic J., Karp B., Ludlow C.L., Miyasaki J.M., Naumann M., and So Y. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70 (2008) 1699-1706
75. Simpson D.M., Gracies J.M., Graham H.K., Miyasaki J.M., Naumann M., Russman B., Simpson L.L., and So Y. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70 (2008) 1691-1698
76. Spencer S.S. When should temporal-lobe epilepsy be treated surgically?. Lancet Neurol. 1 (2002) 375-382
77. Sutton M.A., Wall N.R., Aakalu G.N., and Schuman E.M. Regulation of dendritic protein synthesis by miniature synaptic events. Science 304 (2004) 1979-1983
78. Tafoya L.C., Mameli M., Miyashita T., Guzowski J.F., Valenzuela C.F., and Wilson M.C. Expression and function of SNAP-25 as a universal SNARE component in GABAergic neurons. J. Neurosci. 26 (2006) 7826-7838
79. Tsukamoto K., Kohda T., Mukamoto M., Takeuchi K., Ihara H., Saito M., and Kozaki S. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J. Biol. Chem. 280 (2005) 35164-35171
80. Turton K., Chaddock J.A., and Acharya K.R. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem. Sci. 27 (2002) 552-558
81. Tyler H.R. Botulinus toxin: effect on the central nervous system of man. Science 139 (1963) 847-848
82. Verderio C., Grumelli C., Raiteri L., Coco S., Paluzzi S., Caccin P., Rossetto O., Bonanno G., Montecucco C., and Matteoli M. Traffic of botulinum toxins A and E in excitatory and inhibitory neurons. Traffic 8 (2007) 142-153
83. Verderio C., Pozzi D., Pravettoni E., Inverardi F., Schenk U., Coco S., Proux-Gillardeaux V., Galli T., Rossetto O., Frassoni C., and Matteoli M. SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron 41 (2004) 599-610
84. Verderio C., Rossetto O., Grumelli C., Frassoni C., Montecucco C., and Matteoli M. Entering neurons: botulinum toxins and synaptic vesicle recycling. EMBO Rep. 7 (2006) 995-999
85. von Bartheld C.S. Axonal transport and neuronal transcytosis of trophic factors, tracers, and pathogens. J. Neurobiol. 58 (2004) 295-314
86. Wang J., Meng J., Lawrence G.W., Zurawski T.H., Sasse A., Bodeker M.O., Gilmore M.A., Fernandez-Salas E., Francis J., Steward L.E., Aoki K.R., and Dolly J.O. Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics. J. Biol. Chem. 283 (2008) 16993-17002
87. Wiegand H., Erdmann G., and Wellhoner H.H. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch. Pharmacol. 292 (1976) 161-165
88. Williamson L.C., Halpern J.L., Montecucco C., Brown J.E., and Neale E.A. Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa. J. Biol. Chem. 271 (1996) 7694-7699
89. Wohlfarth K., Schubert M., Rothe B., Elek J., and Dengler R. Remote F-wave changes after local botulinum toxin application. Clin. Neurophysiol. 112 (2001) 636-640
90. Ziemann U., Hallett M., and Cohen L.G. Mechanisms of deafferentation-induced plasticity in human motor cortex. J. Neurosci. 18 (1998) 7000-7007